Stereotaxis, M&A Thursday, July 9, 2026 +0.60 Positive

Stereotaxis completes acquisition of Robocath.

Stereotaxis completed the acquisition of Robocath to combine technologies and strengthen its market position. This strategic move is expected to accelerate innovation and expand the addressable market for endovascular robotic solutions.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day